Why these ASX laggards could start to rally in the next few months

We may soon see the passing of the baton between outperforming ASX growth stocks and underperforming value stocks.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

We may soon see the passing of the baton between outperforming growth stocks and underperforming value stocks.

The bull run seems to have stalled recently and it's the popular growth stocks that are weighing on the S&P/ASX 200 Index (Index:^AXJO).

Questions about their overstretched valuations are likely to linger and that means this could be the time for the laggards to shine.

ASX expensive defensive shares man carrying large dollar sign on his back representing high P/E ratio or dividend

Image source: Getty Images

Why laggards could prove to be better value buys

Value stocks have recently been outperforming growth as the ASX 200 benchmark retreated around 5% from last month's peak.

Growth stocks are those that trading on high price-earnings (P/E) multiples. Investors have been willing to pay a premium for earnings growth in this low-growth COVID-19 environment.

Value stocks are the opposite. The are seen as cheap as their share prices have so far failed to keep pace with the bull market and that puts them on undemanding P/Es.

I suspect some of these underachievers can outperform even if the top 200 stock index trades sideways or slips a little further.

The building stock deepest in value territory

One of these value laggards that I think look interesting is the CSR Limited (ASX: CSR) share price. The uncertain outlook for construction activity is keeping buyers at bay even though the building materials supplier delivered a better than expected full year results in May.

While that may feel like a long time ago on ASX time, investors may again be reminded of this come November when CSR posts its half year results.

UBS thinks profit margins for its building products division will be better than what the market is expecting.

Another catalyst could be the valuation of CSR's 450 hectors of land in Western Sydney, which the market is pricing at around $500 million. Any uplift on land valuation will be warmly received by investors.

The broker is recommending investors buy the stock as it's trading well below its target price of $4.77 a share.

Emerging from an earnings storm

Another laggard I like is the Nufarm Limited (ASX: NUF) share price, which slumped 27% since the start of calendar 2020.

The drought in Australia and Europe weighed on the stock but the adverse weather condition is turning!

Despite this, not much good news is priced into the stock. Also, Nufarm said it would take a $215 million write down in its European assets, so the bar is set reasonably low, in my view.

The turnaround in the stock could come before the end of the month when management hands in its full year results.

It won't be the FY20 numbers that will trigger a rally as management already released the earnings number. It's the outlook statement that investors will be scrutinising. Let's hope management will also have something upbeat to say about sales of its omega-3 enriched canola seeds.

Motley Fool contributor Brendon Lau owns shares of Nufarm Limited. Connect with me on Twitter @brenlau.

The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Cheap Shares

A group of people in suits watch as a man puts his hand up to take the opportunity.
Cheap Shares

A rare buying opportunity in 1 of Australia's top shares?

Here’s why I think it’s a strong long-term buy…

Read more »

Buy and sell keys on an Apple keyboard.
Cheap Shares

2 ASX shares highly recommended to buy: Experts

Many experts like these ASX shares. Here’s why…

Read more »

patient with doctor, medical company, medical insurance
Cheap Shares

CSL shares trade at just 12 times forecast earnings. Here's why they could be the buy of the decade

The ASX 200 healthcare giant is down more than 60% since August 2025.

Read more »

A white and black clock face is shown with Time to Buy written.
Cheap Shares

2 ASX shares tipped to grow 90% or more in the next 12 months

These businesses are expected to deliver significant returns.

Read more »

A man reacts with surprise when her see a bargain price on his phone.
Cheap Shares

This ASX 300 share is down 63% in 2026: Experts think it's a buy!

This business could be a great contrarian buy.

Read more »

A female ASX investor looks through a magnifying glass that enlarges her eye and holds her hand to her face with her mouth open as if looking at something of great interest or surprise.
Cheap Shares

Down 40%+! 2 cheap ASX shares I'd buy before the recovery becomes obvious

The best recovery opportunities can appear before the good news is obvious. I think these two ASX shares are worth…

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Cheap Shares

3 cheap ASX 200 shares to buy with $5,000

Big returns could be on offer with these cheap shares according to analysts.

Read more »

Rising arrow on a piggy bank with a woman holding it and smiling.
Growth Shares

2 ASX growth shares to buy with big growth potential!

Analysts are excited about the prospects of these businesses…

Read more »